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Abstract
Drug resistance is caused by mutations that change the balance of recognition
favoring substrate cleavage over inhibitor binding. Here, a structural dynamics
perspective of the regained wild-type functioning in mutant HIV-1 proteases with
coevolution of the natural substrates is provided. The collective dynamics of
mutant structures of the protease bound to p1-p6 and NC-p1 substrates are
assessed using the Anisotropic Network Model (ANM). The drug-induced prote-
ase mutations perturb the mechanistically crucial hinge axes that involve key sites
for substrate binding and dimerization and mainly coordinate the intrinsic
dynamics. Yet with substrate coevolution, while the wild-type dynamic behavior
is restored in both p1-p6 (LP1
0Fp1-p6D30N/N88D) and NC-p1 (
AP2VNC-p1V82A)
bound proteases, the dynamic behavior of the NC-p1 bound protease variants
(NC-p1V82A and
AP2VNC-p1V82A) rather resemble those of the proteases bound
to the other substrates, which is consistent with experimental studies. The orien-
tational variations of residue fluctuations along the hinge axes in mutant struc-
tures justify the existence of coevolution in p1-p6 and NC-p1 substrates, that is,
the dynamic behavior of hinge residues should contribute to the interdependent
nature of substrate recognition. Overall, this study aids in the understanding of
the structural dynamics basis of drug resistance and evolutionary optimization in
the HIV-1 protease system.
Introduction
Protein interactions mediate the function of biological sys-
tems, where the evolution of interactions is important to
understand the functional mechanism in act (Juan et al.
2008; Lovell and Robertson 2010). Evolutionary signals are
generated either by whole-sequence evolution or by
site-specific coevolution (Lovell and Robertson 2010).
Coevolution can be defined as a reciprocal change in one
site affecting the selection pressure at another site allowing
for adaptation (Thompson 1994). This can occur as either
an intramolecular or an intermolecular process, where
coevolution arises from the evolutionary interaction
between sites within a single molecule in the former, and
the latter is due to co-adaptation as a result of the evolu-
tionary interaction between different molecules (Juan et al.
2008; Lovell and Robertson 2010).
Understanding evolution within the complex relation-
ship between sequence, structure and function for a partic-
ular phenotype is quite limited (Xia and Levitt 2004;
Tomatis et al. 2008). Selective pressures for evolvability
should act at both structural and dynamics levels, where
the sequence divergence is constrained by the conservation
of structural features and further by the conservation of
functional motion. Thus, the functional importance of
protein dynamics should be credited for the sequence evo-
lution (Maguid et al. 2008; Juan et al. 2008). The structural
flexibility and plasticity of proteins are imperative in per-
forming their biological functions, especially in molecular
recognition (Teague 2003; Gerstein and Echols 2004;
Marianayagam and Jackson 2005; Friedland et al. 2009;
Ramanathan and Agarwal 2011; Mittal et al. 2012). The
mechanism of this recognition between proteins and
ligands is probably predefined by the rules encoded in the
© 2014 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative
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protein structure and dynamics, the detailed knowledge of
which would be useful in design and engineering of drugs.
Evolvability and natural variation are also correlated with
drug resistance, which is a central problem in drug design
for many diseases (Earl and Deem 2004; Creavin 2004;
Berkhout and Sanders 2005; Nalam and Schiffer 2008).
Influenza, tuberculosis, malaria, cancer, and HIV/AIDS are
some of the important examples of diseases that confront
drug resistance.
HIV-1 protease is an effective therapeutic target of the
most effective antiviral drugs for the treatment of HIV-1
infection (Prabu-Jeyabalan et al. 2002). The protease is a
symmetric homodimer containing a single active site
formed at the dimer interface by two conserved catalytic
aspartic acid residues, one from each monomer, and cov-
ered by two flexible flaps (Wlodawer and Erickson 1993).
The enzyme recognizes substrate sites on the Gag and Gag-
Pro-Pol polyproteins which are asymmetric in both size
and charge around the cleavage site, while the currently
prescribed inhibitors are relatively symmetric. Yet with the
drug-resistant mutations on the protease, the affinity for
inhibitors is lowered while efficient processing is still main-
tained and the structure reassumes a drastic asymmetry
(Prabu-Jeyabalan et al. 2004). Thus, substrate specificity
should be based on a conserved shape rather than a partic-
ular amino acid sequence. This is explained by a consensus
volume of substrates recognized by the protease, defined as
the ‘substrate envelope’, which not only explains specificity
but also has significant implications for drug resistance and
substrate coevolution (Kolli et al. 2009). The envelope is
achieved by packing of the substrate residues which makes
the substrate recognition interdependent (Prabu-Jeyabalan
et al. 2002; King et al. 2004). This interdependency implies
that a drug-resistant protease mutation that causes unfa-
vorable interactions with one substrate position is often
compensated by a mutation at another position within the
substrate sequence. Two examples of this evolutionary
interplay between substrate and enzyme are the coevolution
of p1-p6 substrate cleavage site with D30N/N88D protease
mutations (Bally et al. 2000) and the coevolution of NC-p1
substrate cleavage site with V82A protease mutation
(Doyon et al. 1996). Furthermore, cleavages at these sites
of Gag, which have the most significant polymorphism
among all HIV-1 substrate sites, are known to be rate limit-
ing steps in polyprotein processing (T€ozser et al. 1991;
Feher et al. 2002).
Most drug-resistant mutations within the protease active
site occur where the inhibitors protrude beyond the sub-
strate envelope and contact the protease (King et al. 2004).
Those protease mutations may be associated with other
mutations in the substrate sites that extend beyond the sub-
strate envelope and/or with other mutations in the viable
protease (Kolli et al. 2006). Substrate dynamics was later
incorporated into the substrate envelope, where p1-p6 and
NC-p1 are shown to be two of the three most dynamic sub-
strates (Ozen et al. 2011). Dynamic substrates exhibit a
worse fit within this dynamic substrate envelope as they
sample a wider conformational space resulting in a greater
deviation from the substrate envelope. Accordingly, the
dynamic p1-p6 and NC-p1 substrates protrude beyond the
dynamic envelope more than expected based on their
molecular volume compared to the other substrates (Ozen
et al. 2011). Thus, the compensatory mutations in these
cleavage sites optimize the portion of the substrate volume
that stays within the dynamic substrate envelope. In the
presence of D30N/N88D mutations in the protease, the
coevolutionary mutation LP10F at the p1-p6 cleavage site
provides a better fit within the dynamic substrate envelope.
Similarly, in NC-p1, the compensatory AP2V substitution
occurs in the presence of V82A mutation in the protease.
The interdependency between the changes in the substrate
sequence in response to the drug-induced protease muta-
tions can be explained by the energetic fitness of the
sequences to the structural space of HIV-1 protease. This
fitness possibly implies a conservation for the dynamic
behavior of the residues in the HIV-1 protease-substrate/
inhibitor complex system. With this approach, the struc-
tural basis of drug resistance, that is, the effect of structural
and dynamic constraints on the sequence evolution (Liu
and Bahar 2012; Gerek et al. 2013), could further be clari-
fied. In this study, we investigate the dynamics to under-
stand the mechanism that results in the dynamic substrate
envelope which was validated as the substrate recognition
motif for HIV-1 protease.
Significant structural and functional features of biomo-
lecular complexes can be elucidated by the detailed analysis
of fluctuations around their native states (Bahar et al.
2010). When dynamics is decomposed into a collection of
modes of motion, the cooperative low frequency/large
amplitude modes have been shown to be significantly cor-
related with the biological function (Nicolay and Sanejou-
and 2006). The principal component analysis (PCA) is a
computational approach to extract the collective behavior
from the fluctuations observed in molecular dynamics
(MD) trajectories (Tournier and Smith 2003). The cooper-
ative motions can alternatively be studied by normal mode
analysis (Ma 2005; Cui and Bahar 2005). Elastic network
models have been well-accepted for studying the large-scale
motion of protein structures in recent years (Chennubhotla
et al. 2005; Nicolay and Sanejouand 2006; Bahar et al.
2010; Gniewek et al. 2012). Despite the simplicity of this
approach, the application of the elastic network models
such as the Gaussian Network Model (GNM) (Bahar et al.
1997; Haliloglu et al. 1997) and the Anisotropic Network
Model (ANM) (Atilgan et al. 2001) to the HIV-1 protease
system have also produced results that are highly in accord
186 © 2014 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd 8 (2015) 185–198
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with those of both experimental studies and MD simula-
tions (Bahar et al. 1998; Zoete et al. 2002; Kurt et al. 2003;
Micheletti et al. 2004; Hamacher and McCammon 2006;
Yang et al. 2008; Hamacher 2010). The computational
studies on the structural dynamics of HIV-1 protease sug-
gest that understanding the dynamic behavior of the
enzyme is crucial for its intrinsic flexibility and function
(Perryman et al. 2004; Hornak and Simmerling 2007; Ozer
et al. 2010).
In protein-ligand interactions, the ligand prefers the
conformations that best match its structural and dynamic
behavior among those intrinsically accessible to the
unbound protein (Bakan and Bahar 2009). The conforma-
tional changes experimentally observed in the enzymes by
binding a broad range of ligands can be predicted by the
most cooperative lowest frequency modes of motion by
ANM, where the hinges are the key mechanistic regions of
the structure that control the conformational ensemble.
Hinge motion has been shown to be an important mecha-
nism that underlies the functional conformational
changes, and catalytic residues tend to be positioned near
the hinge regions that are unique for particular architec-
tures (Yang and Bahar 2005). The elastic distortions of
these dynamically important hinge residues, which serve
as central hubs, effectively trigger the correlated fluctua-
tions of a large number of residues (Zheng and Brooks
2005). Thus, the dynamic behavior of the hinge axes
should mainly determine the flexibility and intrinsic
dynamics of the structure. In our recent work, the ANM
analysis of the fluctuations of the bound HIV-1 protease
structures demonstrated that the hinge residues of the
most cooperative modes display variation in their fluctua-
tions depending on the bound substrate (Ozer et al.
2010). Further, flexible substrates adapt to the conforma-
tional changes of the protease better than the conforma-
tionally and dynamically restricted inhibitors, implying
the rationale for more diverse inhibitors. Here, to study
the dynamic behavior that accompany coevolution in the
HIV-1 protease system, fluctuations of the wild-type,
mutant, and coevolved structures of two protease-sub-
strate complexes, namely the p1-p6 and NC-p1 complexes,
are analyzed by ANM. The results put forward the motive
for the evolutionary optimization of the sequences of




Throughout this article, the wild-type HIV-1 protease
(WT), the HIV-1 protease mutants (D30N, D30N/N88D,
or V82A), and the cleavage site (LP10F or AP2V) variants
in a protease-substrate complex are designated by a sub-
script and a superscript to the name of the cleavage site.
For example, LP1
0Fp1-p6D30N denotes a complex of D30N
protease variant with the LP10F mutant of the p1-p6 cleav-
age site, where LP10F refers to a Leu-to-Phe mutation at
P10 position of the cleavage site. The substrate residues on
the amino-terminal side of the scissile bond and the prote-
ase monomer on that side are termed as unprimed;
whereas, those on the carboxy-terminal side of the scissile
bond are termed as primed.
Structures
The wild-type structures are the crystal structures of HIV-1
protease in complex with its natural substrates downloaded
from the Protein Data Bank (PDB) (Bernstein et al.




AP2VNC-p1V82A variants are modeled in
silico based on their wild-type structures and simulated by
MD simulations. The details of the modeling and MD sim-
ulation protocols were described elsewhere (Ozen et al.
2012). The representative conformations are selected by
clustering the MD sampled conformations.
Cluster analysis on MD simulation trajectories
A representative set of conformations of all wild-type pro-
tease-substrate complexes, p1-p6D30N, p1-p6D30N/N88D,
LP10Fp1-p6D30N/N88D, NC-p1V82A, and
AP2VNC-p1V82A,
generated from MD simulation trajectories of eleven ns
production phase are clustered separately to group the
‘redundant’ conformations and examine the unique
conformers. For the modeled mutant structures that were
run for fifteen ns, the clusters of the endmost snapshots of
eleven ns are used to allow selection of MD-relaxed struc-
tures. The similarity measure to group the MD sampled
conformations is root-mean-square deviation (RMSD) in
this study. MMTSB Toolset’s (Feig et al. 2004) kclust utility
that uses the k-means clustering is used to perform confor-
mational clustering. The convergence of the simulations is
judged by the relative populations of clusters as even fairly
long MD trajectories may not be converged for flexible
systems (Lyman and Zuckerman 2006). The number of
clusters depends on the cutoff value of RMSD (cluster
radius); as RMSD cutoff increases, less number of clusters
are found by the algorithm. With a total of 550 structures
for each HIV-1 protease-substrate complex within eleven
ns, the cluster radius is set as 1.3 A after various trials. The
number of clusters obtained hereby and the percentage of
all the clusters can be seen on Table 1. The percentage
of largest clusters varies between 35% and 86% while
that of the largest two clusters in total varies between 67%
and 100%. Then, the representative structures of the
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largest clusters are further analyzed by ANM. To test the
convergence in the dynamic behavior observed, the repre-
sentative members of the second largest clusters are also
analyzed by ANM and the results are compared with those
of the largest clusters.
Anisotropic Network Model
The simple elastic network models are originally intro-
duced by Tirion (Tirion 1996), where the complex
vibrational properties of macromolecular systems are
reproduced by a model using a single uniform harmonic
potential. GNM (Bahar et al. 1997; Haliloglu et al. 1997)
and ANM (Atilgan et al. 2001) are the two models that
have widely been used in recent years.
Anisotropic Network Model (Atilgan et al. 2001)
predicts the directionalities and magnitudes of the motions
of protein structures around their equilibrium states by a
harmonic vibrational analysis. The conformations that
describe the fluctuations of residues from the average in
the principal directions of motion are generated using the
elastic network formed by connecting all neighboring heavy
atoms. The total potential energy for a system of N nodes is
the summation over all harmonic interactions of close-




hðrc  RijÞðRij  Rij0Þ2
" #
c is the harmonic force constant, and Rij is the instanta-
neous distance, and R0ij is the equilibrium distance between
sites i and j in the native structure. h(rcRij) is the Heavi-
side step function which is 1 if (rcRij) ≥0 and zero other-
wise. rc, the cutoff distance, is taken as 9 A, which has
successfully been used to account for inter-residue interac-
tions in the all-atom structure model of the HIV-1 protease
system (Ozer et al. 2010).
The Hessian matrix H is a 3N 9 3N symmetric matrix,
which holds the anisotropic information regarding the
orientation of nodes i, j. H is composed of N 9 N super
elements Hij each of size 3 9 3 given by the second deriva-
tives of the potential V. An orthogonal transformation of
the real symmetric Hessian matrix gives the normal modes
of the elastic network with 3N  6 nonzero eigenvalues ki









The fluctuations of nodes are used to construct and
explicitly view pairs of alternative conformations sam-
pled in the individual modes, simply by adding the fluc-
tuation vectors to the equilibrium position vectors in
the respective modes. The mode shapes exhibit the dis-
tribution of mobility among residues driven by different
frequency modes, where the minima correspond to
hinge regions.
Orientational correlation analysis
The orientational correlation between the fluctuations in
different structures is assessed by the calculation of the
inner product of the fluctuation vectors. That is, the
structures are superimposed, and cosine of the angle
between their fluctuation vectors is evaluated by a dot
product calculation. The normalized correlation values
range between 1 (perfect correlation, where the angle
between the fluctuation vectors of the superimposed
structures are 0°) and 1 (maximum variation in the
fluctuation direction, where the angle between the fluc-
tuation vectors of the superimposed structures are 180°).
The orientational correlations are assessed on a residue
basis in the two most cooperative modes of motion, to
observe which residues’ fluctuations differ between vari-
ous protease-substrate complex structures. Absolute
lower orientational correlation values indicate the resi-
dues that display larger variations in their fluctuations’
directions.
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Results and discussion
The HIV-1 protease structures investigated in this study are
listed on Table 2. Details of the nomenclature used
throughout the article are described in the Materials and
methods section.
Cooperative motion of protease and substrate
The slow modes describe the most cooperative global
motion of the HIV-1 protease-peptide complex structures
and are likely associated with the enzymatic function of the
protease (Kurt et al. 2003; Yang and Bahar 2005; Yang
et al. 2008). The residue fluctuation profiles in the slowest
two modes share a similar trend in the wild-type and
mutant complexes investigated here (Fig. 1), which is con-
sistent with the earlier results on the wild-type, substrate-
and inhibitor-bound protease structures (Ozer et al. 2010).
The generality of this observation across substrate and
inhibitor complexes of protease variants suggest that the
hinge regions such as the dimerization region (res. 5–10),
the active site (res. 25–27), the flap (res. 45–55), and the
substrate cleft (res. 80–90) display the least fluctuations in
their mean positions and coordinate the motion. The dis-
tribution of the mean-square fluctuations in p1-p6 and
NC-p1 bound protease structures analyzed here displays
that residues 56, 69, 78, 93 and residues 25–27, 49–51, 84,
97 are observed to be at the minima of the corresponding
mode shapes, in the first (Fig. 1A,C) and second (Fig. 1B,
D) slowest modes, respectively.
The motion of a ligand-bound HIV-1 protease is demon-
strated for one representative structure in Fig. 2. In the
slowest mode (Fig. 2A), the protease monomers rotate
around two axes parallel to the Z direction, coupled with
the peptide fluctuation along the Y direction. In second
slowest mode (Fig. 2B), the monomers rotate around two
different axes parallel to X and Z directions and the peptide
motion is significant in the terminal residues. The hinge
axes in the corresponding modes are shown as dashed lines.
As the functional conformational changes are mainly
due to elastic distortions of the hinge residues that trigger
the correlated fluctuations (Zheng and Brooks 2005), the
dynamic behavior of the hinge axes, that is, the fluctuation
of residues located at the hinge sites, should determine the
flexibility and intrinsic dynamics of the bound protease.
Here, the hinge regions suggested by the slowest mode
mainly coordinate the intrachain cooperative motions
along with the motion of the peptide, whereas those sug-
gested by the second slowest mode are mostly responsible
for the correlations across the dimerization interface
(Fig. 2).
Deformation of hinge axes by protease mutations and
coevolution: the orientational variations in the
fluctuations of hinge residues
Among different complex structures of the wild-type
protease, although the overall residue mobility profiles
are similar (Fig. 1), some variations in the amplitude
and the orientation of the residue fluctuation vectors
might be possible. The substrate stabilizes one of the
several conformations accessible to the protease function-
ally and energetically favorable (from both thermody-
namic and kinetic aspects). For example, the protease’s
interaction with a specific substrate should corroborate
the substrate kinetics, that is, the rate of cleavage. Struc-
tural variations across substrate complexes should be
reflected in specific recognition of substrates, so should
be the difference in their dynamic behavior. This pre-
sumable difference is therefore investigated further by
the orientational correlations between the residue fluctu-
ations in mutant structures.
In the ANM analysis of the dynamics of the wild-type
HIV-1 protease structures bound to its natural sub-
strates, the highest orientational differences in the resi-
due fluctuations and the largest extent of the asymmetry
of the residue fluctuations in the two protease mono-
mers were observed primarily along the hinge axes (Ozer
et al. 2010). This suggests that there is a substrate-spe-
cific behavior implicated therein in relevant modes
(Fig. 2) by the fluctuations of hinge residues. Here,
the premise is whether the specific dynamic interaction
of each substrate with the protease should be conserved
or not. To this end, the inquiry is whether or not the
drug-induced protease mutations associated with the
coevolution of the substrate would corroborate this
specific interaction by the re-orientation of fluctuations
of hinge residues back to those of the wild type. The
analysis of the orientational correlations (see Materials
and methods) of the residue fluctuations among
the mutant and the coevolved mutant structures will
Table 2. HIV-1 protease-substrate complex structures used in the
analyses.










Coevolved mutant structures LP1
0Fp1-p6D30N/N88D
AP2VNC-p1V82A
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provide a dynamic mechanistic perspective for the role
of mutations.
Coevolution in p1-p6
The residue fluctuations in the slowest two modes of
p1-p6D30N, p1-p6D30N/N88D, and
LP10Fp1-p6D30N/N88D
variants are compared with those of p1-p6WT (Fig. 3). The
correlation coefficient values between the fluctuation vec-
tors of each residue in the two respective structures indicate
the orientational (directional) variation in their fluctua-
tions in the given mode. With the protease mutations, the
largest orientational difference in the fluctuations is
observed mostly at the proximity of residue 69 in the
unprimed monomer and at residues 56, 78, 93 in both
monomers in the slowest mode (Fig. 3A). In the second
slowest mode, the fluctuations of residues 25, 26, 27, 39 in
the unprimed monomer and residues 16, 49, 50, 51, 97 in
both monomers display largest orientational difference
(Fig. 3D). These residues lie at the hinge axes of rotational
motion identified by the residue mobility profiles in Fig. 2.
The correlation coefficients of the residue fluctuation
vectors between p1-p6WT and
LP10Fp1-p6D30N/N88D in both
modes are in general higher than they are between
p1-p6WT and p1-p6D30N/N88D. To quantify, when the resi-
dues with maximum variations in their orientational correla-
tions that are below the lower standard deviation bound
(average minus one standard deviation) are considered, the
average correlation coefficient value which is 0.61 between
p1-p6WT and p1-p6D30N/N88D increases to 0.90 between
p1-p6WT and
LP10Fp1-p6D30N/N88D in the slowest mode.
Similarly, in the second slowest mode, the average correla-
tion coefficient value between p1-p6WT and p1-p6D30N/N88D
is 0.63, whereas it is 0.69 between p1-p6WT and
LP10Fp1-
p6D30N/N88D. In both modes, the correlation of p1-p6D30N
with p1-p6WT is even less than that of p1-p6D30N/N88D which
has the signature mutations of nelfinavir resistance that
occur in association with p1-p6 cleavage site mutations (Kolli
et al. 2009).
The residues that display the maximum variations
between the directions of fluctuations can also be visualized
on the structures in Fig. 3, as color coded according to the
change in the correlation values of p1-p6D30N/N88D
(Fig. 3B,E) and LP1
0Fp1-p6D30N/N88D (Fig. 3C,F) compared
to p1-p6WT. In the slowest mode, the higher correlation
(A) (B)
(C) (D)
Figure 1 Mean-square fluctuations of the p1-p6 and NC-p1 bound protease complex structures in the first (A, C) and in the second (B, D) slowest
Anisotropic Network Model (ANM) modes. The fluctuations are calculated for all the atoms in the structures, but for clearer representation, the fluc-
tuations of Ca atoms are plotted, and the corresponding residue numbers are indicated on the x-axis.
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(A)
(B)
Figure 2 The regions of the orientational difference in the direction of fluctuations in the first (A) and second (B) slowest Anisotropic Network Model
(ANM) modes. The least correlating residues in their fluctuations’ directions between different complex structures of HIV-1 protease are displayed in
magenta in the front view. Top and side views of the structure are shown, where the residue fluctuations in each mode are represented as moving
between the conformations shown in green and red for the protease, and in green and blue for the peptide. The dashed lines indicate the hinge axes
around which the monomers rotate. The coordinate system for the front, top, and side views is indicated next to the structures.
© 2014 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd 8 (2015) 185–198 191
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values of residues 67, 68, 69, 560, and 780 between
LP10Fp1-p6D30N/N88D and p1-p6WT structures compared to
those between p1-p6D30N/N88D and p1-p6WT structures are
evident (Fig. 3B,C). On the other hand, the highest
increase in the correlation values with p1-p6WT structure as
a result of coevolution is observed for residues 25, 26, 27,
and 39 in the second slowest mode (Fig. 3E,F).
The correlated mutations at residues 30 and 88 lead to a
significant change in the orientation of the fluctuations of
residue 69 in the slowest mode, which leads to the dramatic
difference in the dynamic behavior with an additional
asymmetry between the two monomers of the protease.
The other significant changes in the fluctuation orientation
in this mode are at residues 560 and 780. Nevertheless, with
the coevolving mutation at P10 site in the substrate, the
re-orientation of the fluctuations of these residues close to
their wild-type position is observed remarkably (Fig. 3A–
C). Residues 56 and 78, being flap and substrate cleft resi-
dues with low mobility, are found at the hinge region that
connects the 40’s and 70’s loops to the flaps, respectively.
Residue 69 is found on the 70’s loop which moves in a
manner of a cantilever with the flaps, where flaps close as
the cantilever moves up (Lebon and Ledecq 2000). There-
fore, the motion of residues 56, 69, and 78 is coupled to the
motion of the flaps, which is known to be the significant
functional motion of the protease (Nicholson et al. 1995;
Kurt et al. 2003; Hornak and Simmerling 2007). The
importance of such protease regions which interact with
the flaps is implied in studies of developing allosteric inhib-
itors for HIV-1 protease that do not compete for the active
site, where they are targeted as allosteric sites (Lebon and
Ledecq 2000; Perryman et al. 2004; Hornak and Simmer-
ling 2007; Yang et al. 2012). On the other hand, in the sec-
ond slowest mode, protease mutations lead a fluctuation
orientation difference particularly at residue 39 in the
unprimed monomer together with the active site and
dimerization interface residues, which is recovered by the
coevolving mutation on the substrate (Fig. 3D–F). Residue
39 has high mobility in the slowest mode yet acts as a hinge
in the second slowest mode, where it interacts and fluctu-
ates in the opposite direction with the flaps of the same
monomer (Ozer et al. 2010). Due to this anticorrelated
behavior with the flap motion, 39 is also an important resi-
due which has been considered as a potential allosteric
inhibition site (Tozzini and McCammon 2005). By intro-
ducing mutations and specific cross-links at residues
around 39 to restrict the hydrophobic core rearrangements,
the essential role of core flexibility in modulating the activ-
ity of HIV-1 protease has been demonstrated (Mittal et al.
2012).
The most variation being in the orientation of the fluctu-
ations around the hinge axes implies that the protease
mutations perturb the mechanistically crucial sites that
mainly coordinate the intrinsic dynamics of the protease in
interaction with its substrate. The protease mutations with
the example of p1-p6 substrate complex here show the
(A) (B) (C)
(D) (E) (F)
Figure 3 Orientational correlation of the protease residues’ fluctuations of p1-p6D30N, p1-p6D30N/N88D, and
LP10Fp1-p6D30N/N88D to those of p1-
p6WT in the first (A) and second (D) slowest modes. The residues that display the maximum variations between the directions of fluctuations are
color coded according to the change in the correlations of p1-p6D30N/N88D and
LP10Fp1-p6D30N/N88D compared to p1-p6WT; (B) and (C) in the first
slowest mode, and (E) and (F) in the second slowest mode, respectively. The line plot connecting the points that indicate the correlation values
is used to guide the eye.
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deformation of the hinge axes, representing a global defor-
mation with local perturbations. Nevertheless, the fluctua-
tions in the coevolved structure have the highest
correlation with that of the wild-type structure among
other mutant structures. The deformation in the direction
of fluctuations and the additional asymmetry of the prote-
ase monomers is recovered considerably by this coevolu-
tion. This provides a more comprehensive view with
dynamics incorporated as an additional dimension, rather
than just the structural information about the positions of
the mutations.
The structures of p1-p6 bound protease studied here are
the representative conformations of the largest of five,
three, and four clusters in p1-p6WT, p1-p6D30N/N88D, and
LP10Fp1-p6D30N/N88D MD simulation trajectories, respec-
tively (Table 1). Then, the ANM analyses of the representa-
tive members of the second largest clusters are also
investigated. In the most cooperative modes of motion of
these structures, the maximum orientational variations are
observed in the same residues that lie along the hinge axes
in p1-p6WT where the directions of their fluctuations are
significantly distorted in p1-p6D30N/N88D. On the other
hand, these variations in the fluctuation directions of the
hinge residues of LP1
0Fp1-p6D30N/N88D largely remain within
the variations observed in p1-p6WT compared to those
observed in p1-p6D30N/N88D.
Coevolution in NC-p1
Figure 4 displays the orientational correlation values of the
fluctuation vectors of protease residues of NC-p1V82A and
AP2VNC-p1V82A with respect to NC-p1WT for the slowest
two modes. The residues of the protease mutant that dis-
play the largest orientational difference in their fluctuations
with respect to the wild type are 56, 69, 78, 93 in both
monomers in the slowest mode (Fig. 4A). In the second
slowest mode, the fluctuations of residue 39 in the
unprimed monomer and residues 25, 26, 27, 49, 50, 51, 97
in both monomers display the largest orientational differ-
ence as a result of the protease mutation (Fig. 4D). These
residues with largest deviations in their orientations lie
along the hinge axes of rotational motion in both modes
(Fig. 2), and they are found at almost identical sites in the
p1-p6 and NC-p1 bound structures, where they interact
with functional regions such as flaps and cleft covering the
active site.
The correlation coefficients of the residue fluctuation
vectors between NC-p1WT and
AP2VNC-p1V82A in both
modes are higher than they are between NC-p1WT and
NC-p1V82A, yet the increases in the correlations are not as
significant as in p1-p6. By considering the residues with
maximum variations in their orientational correlations
that are below the lower standard deviation bound (aver-
age minus one standard deviation), it is assessed that the
average correlation coefficient value which is 0.45 between
NC-p1WT and NC-p1V82A increases to 0.58 between
NC-p1WT and
AP2VNC-p1V82A in the slowest mode. In the
second slowest mode, the average coefficient value does not
improve much (0.026–0.052, respectively) for the correla-
tions of NC-p1WT with NC-p1V82A and
AP2VNC-p1V82A.
The relatively low increase in the average correlation values
is due to the opposing behavior observed in the residues as
a result of coevolution; some correct their fluctuations
while some fluctuate more diversely with respect to the
wild type.
The structures in Fig. 4 display the residues that exhibit
the maximum variations between the directions of fluctua-
tions, as color coded according to the change in the
correlation values of NC-p1V82A (Fig. 4B,E) and
AP2VNC-
p1V82A (Fig. 4C,F) compared to NC-p1WT. In the slowest
mode, the correlations of residues 66, 69, 89, 92, 93, 770,
890, and 930 between AP2VNC-p1V82A and NC-p1WT are
higher than their correlations between NC-p1V82A and
NC-p1WT (Fig. 4B,C). In the second slowest mode, an
increase in the correlation values with NC-p1WT as a result
of coevolution is observed for residues 25, 26, 27, 28, and
97 of both monomers, whereas the correlation values of
residues 49, 50, and 51 on the flap regions decrease
(Fig. 4E,F).
Additionally, the protease mutation at residue 82 causes
the difference in the dynamic behavior with an additional
asymmetry between the protease monomers, particularly
by the change in the orientation of the fluctuation of resi-
due 93 in the slowest mode and residue 97 in the second
slowest mode. The deformed orientations of the residue
fluctuations return closer to their behavior in the wild-type
dynamics by the consequent coevolving mutation at P2 site
in the NC-p1 substrate (Fig. 4). The importance of the
dimerization interface regions was also emphasized in
allosteric inhibition studies of HIV-1 protease: Besides the
allosteric inhibition studies targeting the flap motion of
HIV-1 protease, another class of allosteric inhibitors inves-
tigated are dimerization inhibitors that would prevent the
formation of the active protease homodimer by binding to
the dimerization interface (Hornak and Simmerling 2007;
Yang et al. 2012).
The structures of NC-p1 bound protease studied here are
the representative conformations of the largest of four,
three, and five clusters in NC-p1WT, NC-p1V82A, and
AP2VNC-p1V82A MD simulation trajectories, respectively
(Table 1). As in p1-p6 bound structures, the representative
members of the second largest clusters are also investigated
by ANM. The residues that lie along the hinge axes affirm
maximum orientational variations with significant distor-
tions in the directions of their fluctuations in NC-p1V82A in
the most cooperative modes of motion. Furthermore, the
variations in the fluctuation directions of the hinge residues
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of AP2VNC-p1V82A remain within the variations observed in
NC-p1WT compared to those observed in NC-p1V82A.
Here, within the NC-p1 structures in the slowest two
modes, higher correlation is observed in most of the hinge
residues between wild-type and coevolved complex struc-
tures compared to that between wild-type and V82A
mutant, resembling the orientational correlations within
the p1-p6 structures. Yet, the lower correlations between
the wild-type and the coevolved structures of NC-p1 com-
pared to those in the p1-p6 structures, as well as the
decreasing correlations for some of the hinge residues, sug-
gest that the repossession of the structural dynamics as a
result of the re-orientation by the coevolutionary mutation
in the NC-p1 site is not as strong as that in the p1-p6 site.
Coevolved NC-p1 and other substrate complex structures
The dynamics of mutant NC-p1 complex structures are
also studied with respect to that of the wild-type structures
of HIV-1 protease bound to the natural substrates other
than the NC-p1 itself, namely MA-CA, CA-p2, p2-NC,
p1-p6, RT-RH, and RH-IN. The orientational correlations
of the fluctuation vectors of protease residues of the NC-p1
complex structures with those of the wild-type complex
structures of each of the other six natural substrates are cal-
culated separately, and the average correlation per residue
position over six correlation values is computed. The orien-
tational correlation of protease residues of NC-p1WT,
NC-p1V82A, and
AP2VNC-p1V82A with respect to the average
of the wild-type structures of the other six natural
substrates in the two most cooperative modes of motion is
displayed in Fig. 5. The residues that display the maximum
orientational difference in their fluctuations are observed at
the similar hinge regions as in the previous cases, specifi-
cally at proximity of residues 56, 69, 78, 89, and 93 of both
monomers in the slowest mode (Fig. 5A), and at residues
39 of the unprimed monomer, 97 of the primed monomer,
and 25, 26, 27, 28, 52 of both monomers in the second
slowest mode (Fig. 5D). The importance of these hinge
regions in both function and allosteric communication,
being either residues of the active site (25–28), the flaps
(52, 56), the substrate cleft (78, 89), the dimerization inter-
face (93, 97), or those exhibiting linked motion with the
functionally important flaps (39, 69), should be noted
(Lebon and Ledecq 2000; Perryman et al. 2004; Tozzini
and McCammon 2005; del Sol et al. 2006; Hornak and
Simmerling 2007).
In both modes, the correlations of the residue fluctuation
vectors of the hinge regions in each of the natural substrate
complexes other than NC-p1 with both of the mutant
NC-p1 complex structures are higher compared to those
with the wild-type NC-p1 complex structure. The correla-
tion coefficients calculated over the least correlating resi-
dues (having correlation values below the lower standard
deviation bound) are 0.64, 0.84, and 0.87 in the slowest
mode and 0.32, 0.59, and 0.57 in the second slowest mode
in turn for NC-p1WT, NC-p1V82A, and
AP2VNC-p1V82A with
respect to the average of the wild-type structures of the
(A) (B) (C)
(D) (E) (F)
Figure 4 Orientational correlation of protease residues’ fluctuations of NC-p1V82A and
AP2VNC-p1V82A to those of NC-p1WT in the first (A) and sec-
ond (D) slowest modes. The residues that display the maximum variations between the directions of fluctuations are color coded according to the
change in the correlations of NC-p1V82A and
AP2VNC-p1V82A compared to NC-p1WT; (B) and (C) in the first slowest mode, and (E) and (F) in the second
slowest mode, respectively. The line plot connecting the points that indicate the correlation values is used to guide the eye.
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other six natural substrates. It appears that the correlation
between the NC-p1 complex structure with the other natu-
ral substrate bound structures increases as a result of the
mutation V82A in the protease. However, with the consec-
utive coevolving mutation AP2V in the substrate, this cor-
relation does not increase significantly yet decreases slightly
in the second slowest mode.
The residues with maximum orientational differences
between their directions of fluctuations can also be
observed on the structures in Fig. 5, as color coded accord-
ing to the change in the correlation of the NC-p1WT
(Fig. 5B,E) and AP2VNC-p1V82A (Fig. 5C,F) compared to
the average of the wild-type protease structures bound to
the other six natural substrates. As a result of the mutations
in the protease and the NC-p1 substrate, the residues of the
hinge regions explicitly mentioned above exhibit increased
correlations with the rest of the natural substrate bound
protease structures.
Here, it is interesting to note the higher number of pro-
tease residues in NC-p1V82A and
AP2VNC-p1V82A possessing
higher correlations with those in the wild-type complex
structures bound to the rest of the natural substrates. This
is consistent with the structural rationale for HIV-1 prote-
ase binding to the NC-p1 cleavage site given in Prabu-Jey-
abalan’s work (Prabu-Jeyabalan et al. 2004), where they
solved the crystal structures of wild-type and V82A mutant
proteases in complex with their respective wild-type and
AP2V mutant NC-p1 substrates. They observed that the
AP2V mutant peptide bound the mutant protease more
optimally than the wild-type NC-p1 peptide bound the
wild-type protease. That is, the AP2V mutation on the pep-
tide coevolving with the V82A mutation on the protease
re-orients the peptide to a conformation which is more
similar to those of the other natural substrate-protease
complexes than the NC-p1 (Prabu-Jeyabalan et al. 2004).
In the analyses outlining the coupling between catalysis
and conformational mechanics, there is growing evidence
that enzymatic activity results from a delicate interplay
between chemical kinetics and molecular motions (Yang
and Bahar 2005). The catalytic sites are found at proximity
of binding sites which enjoy flexibility to accommodate the
ligand binding, and the accompanying large-scale confor-
mational changes are connected to the hinge motion
(Ferreiro et al. 2011). Overall, the variation in the residues
at the hinge regions of HIV-1 protease in the functional
modes is required for the protease to process different sub-
strates, which results in specific cleavage rates for the
proper functioning of the virus life cycle. Therefore, the
interdependent nature of the substrate recognition allowing
the protease to recognize various nonhomologous
sequences as natural substrates may be partly due to this
adaptability in the hinge regions which are the mechanisti-




Figure 5 Orientational correlation of protease residues’ fluctuations of NC-p1WT, NC-p1V82A, and
AP2VNC-p1V82A to those of the averaged wild-type
natural substrate complexes other than NC-p1 in the first (A) and second (D) slowest modes. The residues that display the maximum variations
between the directions of fluctuations are color coded according to the change in the correlation of NC-p1WT and
AP2VNC-p1V82A compared to the
averaged wild-type natural substrate complexes other than NC-p1; (B) and (C) in the first slowest mode, and (E) and (F) in the second slowest mode,
respectively. The line plot connecting the points that indicate the correlation values is used to guide the eye.
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Conclusion
Structural dynamics analyses contribute largely to the
understanding of functional and evolutionary properties
of proteins, which suggest that the preservation of
dynamic properties is critical for maintaining the biolog-
ical function (Gerek et al. 2013). The global motions of
the proteins are described by the most cooperative nor-
mal modes of the ANM. These modes have the highest
contribution to the flexibility profiles, and they are
predominantly defined by the proteins’ architecture.
Therefore, they are generally functionally relevant, evolu-
tionarily conserved and are more robust with respect to
mutational perturbations (Liu and Bahar 2012). Also,
the conserved hinge regions identified in these conserved
modes are shown to play decisive roles in conforma-
tional transitions induced by binding. Here, the exami-
nation of the structural and dynamic properties of the
mutant and coevolved structures of p1-p6 and NC-p1
substrate complexes contributes to the understanding of
the binding as well as the drug-resistant mechanism of
HIV-1 protease. Overall, there seems to be interplay
between the variation in the fluctuations of the impor-
tant hinge regions and the variation in the substrate
sites of the protease in regard to functionality. That is, a
plausible complex dependence between the hinge behav-
ior and the specific functionality of the substrate with
respect to the rate of cleavage can be inferred. The
mutation in the substrate allows the protease residues to
re-orient and thus fluctuate as in the functional confor-
mation, and justify the existence of this coevolutionary
mutation for the conservation of, at least, the fluctua-
tions and flexibility.
Understanding the determinants of ligand recognition
and binding in sequence, structure, function, and
dynamics paradigm is now a major challenge in drug
discovery. The structural data for target proteins with
different ligands display the contribution coming from
both partners in selecting the bound forms. The intrinsic
dynamics of proteins appears to be optimized by evolu-
tion for functional interactions, yet the ligand selects the
one that best fits its structural and dynamic properties
among the conformations accessible to the unbound
protein. In binding, the variety of ligands with different
compositions and shapes as well as affinity and selectiv-
ity can be explained by the conformational flexibility of
receptors. Being related to dynamics and evolution, flexi-
bility should also have impacts on structural divergence
connected to the orientational difference in the fluctua-
tion of the molecules. This implies that drug-resistant
studies should go beyond the concept of inhibition of
structure to the concept of inhibition of functional
dynamics by focusing on flexibility as well.
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